Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - NUTRACEUTICAL INTERNATIONAL CORPnutr-ex9912116.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 1, 2016
 
NUTRACEUTICAL INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter) 
 
Delaware
(State of incorporation)
000-23731 
(Commission
File Number)
87-0515089 
(IRS Employer
Identification No.)

1400 Kearns Boulevard, 2nd Floor
Park City, Utah
(Address of principal executive offices)
84060
(Zip Code)

Registrant's telephone number, including area code: (435) 655-6106 
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





1



Item 8.01 Other Events.
On December 1, 2016, Nutraceutical International Corporation (“Nutraceutical”) announced that its Board of Directors has declared a quarterly cash dividend on Nutraceutical's common stock. The declared quarterly dividend of $0.125 per share is payable on January 5, 2017 to stockholders of record on December 20, 2016. The press release reporting this announcement is attached to this Form 8-K as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits

Exhibit
Number
 
Description
 
 
99.1
 
Press release issued by Nutraceutical dated December 1, 2016




2





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
NUTRACEUTICAL INTERNATIONAL CORPORATION
(Registrant)
Date: December 1, 2016

By:      /s/ Cory J. McQueen                                                                                                `             
      Cory J. McQueen
       Vice President and Chief Financial Officer
       (Principal Financial and Accounting Officer)
 
 

3



EXHIBIT INDEX


Exhibit
Number
 
Description
 
 
99.1
 
Press release issued by Nutraceutical dated December 1, 2016


4